Agree, given this is a "technical" issue in the contract, if Fuji do muck around, then they have left the door wide open now with the drop and the only thing a potential Bayer, Merck, CSL or whoever would loose is the tiny GvHD indication which was not the main game, just the proving ground to launch into P2s.
The much bigger game for large pharma is CLI, OA, Wound Care, Asthma etc etc and on and on
The smelly part is why 6 months.
Ann: Cynata Extends FUJIFILM Licence Option in GvHD, page-189
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.015(6.52%) |
Mkt cap ! $34.32M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 21.5¢ | $15.12K | 67.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30833 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 13.49pm 03/12/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
